Senior insider sale
MAZE THERAPEUTICS, INC. — senior position signals high conviction
$1.41M
37.50K shares
What this filing means
KATHIRESAN SEKAR plans to sell 37.50K shares of MAZE THERAPEUTICS, INC. valued at approximately $1.41M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/4/2025ACC: 0001950047-25-009757
37.50K
Shares to sell
$1.41M
Approx. market value
10K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Founder Stock
Cash
11/1/2018
10KTotal acquired10K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
11/1/2018 | Founder Stock Cash | 10K | — |
| Total | 10K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
27.50K
Market value
$984.6K
11/21/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
10K
Market value
$425.4K
12/4/2025
Total
Units
37.50K
Value
$1.41M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
11/21/2025 | 27.50K | $984.6K | — | Completed |
| Planned — Approximate Date | ||||
12/4/2025 | 10K | $425.4K | NASDAQ | Planned |
| Total | 37.50K | $1.41M | ||